Joya Heart, MD | |
483 S Loop Rd, Edgewood, KY 41017-5446 | |
(859) 301-4600 | |
Not Available |
Full Name | Joya Heart |
---|---|
Gender | Female |
Speciality | Student In An Organized Health Care Education/training Program |
Location | 483 S Loop Rd, Edgewood, Kentucky |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1750453585 | NPI | - | NPPES |
00G797910 | Medicaid | CA |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208000000X | Pediatrics | G79791 (California) | Secondary |
390200000X | Student In An Organized Health Care Education/training Program | FT591 (Kentucky) | Primary |
Mailing Address | Practice Location Address |
---|---|
Joya Heart, MD 483 S Loop Rd, Edgewood, KY 41017-5446 Ph: (859) 301-4600 | Joya Heart, MD 483 S Loop Rd, Edgewood, KY 41017-5446 Ph: (859) 301-4600 |
News Archive
Wellness Center USA, Inc., a Schaumburg IL based healthcare and nutraceutical company, reported the closing of its Psoria-Shield Inc. (PSI) acquisition. PSI is a Tampa, FL based developer and manufacturer of UltraViolet (UV) phototherapy devices for the treatment of skin diseases.
United Surgical Partners International, Inc. today announced results for the fourth quarter and year ended December 31, 2011.
New research findings published in the March issue of the Journal of the American College of Surgeons indicate that some breast cancers continue to be detected as a palpable lump rather than being found through mammographic screening.
Sanofi US announced today results of the pivotal SAVE-ONCO study which demonstrated that, in cancer patients initiating a chemotherapy regimen, investigational semuloparin significantly reduced the risk of the composite of symptomatic-deep vein thromboembolism (DVT), non-fatal pulmonary embolism (PE) or venous thromboembolism (VTE)-related death by 64%, meeting the study primary endpoint.
› Verified 6 days ago